Immunogenicity of Trivalent Influenza Vaccine in Extremely Low-birth-weight, Premature versus Term Infants. ... (HA) units in 0.025 mL of the virus suspension. H1, H3, B/Victoria, ...

Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates.

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced ...

The trial did not meet one of its primary immunogenicity objectives of non ... Pfizer’s and BioNTech’s mRNA-based combination vaccine candidate for influenza and COVID-19, the flu and ...

Phase 1/2 H5 avian flu vaccine study shows positive interim results. Company has been notified that HHS will terminate Moderna's award for late-stage development of pre-pandemic influenza vaccines ...

The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s currently authorized COVID-19 vaccine and a licensed seasonal influenza vaccine.

Phase 1/2 H5 avian flu vaccine study shows positive interim results. Company has been notified that HHS will terminate Moderna's award for late-stage development of pre-pandemic influenza vaccines ...

Phase 1/2 H5 avian flu vaccine study shows positive interim results. Company has been notified that HHS will terminate Moderna's award for late-stage development of pre-pandemic influenza vaccines ...

Goswami J, Cardona JF, Hsu DC, et al. Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded ...

Higher immune responses were elicited by mRNA-1083 than SD-IIV4 (50 to 64 years) for all 4 influenza strains and HD-IIV4 (65 years and older) for 3 influenza strains, and against SARS-CoV-2 (all ...